Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer: Targeted Screening in Men at Higher Genetic Risk and Controls

NCT00261456 is registered in ClinicalTrials.gov with Institute of Cancer Research, United Kingdom as lead sponsor.

NCT NCT00261456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00261456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer: Targeted Screening in Men at Higher Genetic Risk and Controls
Lead sponsor
Institute of Cancer Research, United Kingdom
Phase
Observational
Overall status
Active, not recruiting
Start date
March 31, 2005
Completion date
March 31, 2030
Enrollment
3,500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brca mutation, genetic predisposition to disease, mismatch repair gene mutation, prostate cancer